Brief review on analysis of Prazosin Hydrochloride
DOI:
https://doi.org/10.7439/ijapa.v5i4.2918Keywords:
amniotic band sequence, pseudoainhum, meningoceleAbstract
Prazosin is one of the alphaone adrenoreceptor blocker used in hypertension, benign prostatic hyperplasia, prostate cancer etc. The alpha blockers are relatively inexpensive and exert their effects quickly and Prazosin is the most commonly used alpha blocker. This review highlights various analytical methods for the determination of Prazosin hydrochloride in different matrices. Analytical methods reported are classified into four categories viz; spectrophotometry, chromatography, pharmacopoeial and other methods. The methods were described in terms of sensitivity (LOD and LOQ), linear range, principle and its applicability. This review also briefly highlights pharmacology of prazosin. This review is helpful for the researchers and scientists studying Prazosin hydrochloride in its analytical and pharmacological aspect.Downloads
References
The Merck Index, 15th edition, RSC Publishing, Cambridge, UK, 2013, pp. 1430.
Jaillon P. Clinical pharmacokinetics of prazosin. Clin Pharmacokinet. 1980; 5(4):365-76.
Charlton M, Thompson J, Drugs acting on the heart: antihypertensive drugs, Anaesthesia and intensive care medicine. 2015. http://dx.doi.org/10.1016/j.mpaic.2015.02.007.
Tahmatzopoulos A, Rowland RG, Kyprianou N. The role of alpha-blockers in the management of prostate cancer. Expert Opin Pharmacother. 2004; 5(6):1279-85.
Lin SC, Chueh SC, Hsiao CJ, Li TK, Chen TH, Liao CH, Lyu PC, Guh JH. Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycle. Neoplasia. 2007; 9(10):830-9.
Perinchery Narayan, Manoj Patel, Ashutosh Tewari. Options for treatment of Benign Prostatic Hyperplasia: Alpha-blockers. In Advanced Therapy of Prostate Disease. Martin I. Resnick, Ian M. Thompson (ed), 2000, B.C. Decker Inc. pp. 532-533
Alpha-adrenoceptor antagonists. Meyler
Donatella Boschi, Antonella Di Stilo, Roberta Fruttero, Claudio Medana, Giovanni Sorba, and Albert0 Gasco. ?1-Adrenoceptor Blocking Activity of Some Ring-open Analogues of Prazosin. Archiv der Pharmazie, 1994, 327(10), 661
Kung S, Espinel Z, Lapid MI. Treatment of nightmares with prazosin: a systematic review. Mayo Clin Proc. 2012; 87(9):890-900. doi: 10.1016/j.mayocp.2012.05.015.
Vardanyan RS, Hruby VJ. Synthesis of Essential Drugs. Elsevier, 2006, pp. 170.
Chernyshev VV, Stephens PW, Yatsenko AV, Ryabova OB, Makarov VA. Structural characterization of prazosin hydrochloride and prazosin free base. J Pharm Sci. 2004; 93(12):3090-5.
Kostek LJ. Analytical Profiles of Drug Substances. Prazosin Hydrochloride. Volume 18, Klaus Florey (Editor), Academic press, Inc. pp. 1990, 351
Shrivastava A, Jain M, Varshneya R. Determination of doxazosin in different matrices: a review. International Journal of Advanced Chemistry. 2014;2(2): 109-116.
Heba H. Abdine, Abdel Fatah M, El Walily, Mohammed A. Korany. Spectrophotometric and spectrofluorometric determination of prazosin. Saudi Pharmaceutical Journal. 1995; 3(4): 192-195.
Arranz A, de Beto
Panzova B, Ilievska M, Trendovsica G, Bogdanov B. Simultaneous determination of polythiazide and prazosin in tablets by second-order derivative UV spectroscopy, Int. J. Pharm., 1991;70(1-2):187-190.
Abdel-Gawad FM. Spectrophotometric determination of some pharmaceutical piperazine derivatives through charge-transfer and ion-pair complexation reactions. J Pharm Biomed Anal. 1997; 15(11):1679-85.
Sreedhar K, Sastry CS, Narayana Reddy M, Sankar DG. Spectrophotometric methods for the determination of prazosin hydrochloride in tablets. Talanta. 1996; 43(11):1847-55.
Shabana NS. Development and validation of simple UV-spectrophotometric method for quantification of prazosin in API and solid dosage formulation. Innov J Quality Assur Pharma Analysis 2015; 1(1):110-114.
Rani GD, Rao CN, Rao CN, Narayana A, Venkateswarlu P. Sensitive Spectrophotometric Method for the Determination of Prazosin. Indian J Adv Chem Sci 2015; 3(4):328-332.
Elwy HM, Mohammed TA. New Spectrophotometric and Spectrofluorimetric Methods for Determination of Prazosin HCl in API and Drug Product. Inter J Sci Res 2015; 4(7): 1748-1755.
Wood AJ, Bolli P, Simpson FO. Prazosin in normal subjects: plasma levels, blood pressure and heart rate. Br. J. clin. Pharmac. 1976; 3:199-201.
Ni Y, Liu G, Kokot S. Fluorescence Spectrometric Study on the Interactions of Terazosin Hydrochloride and Prazosin Hydrochloride with Bovine Serum Albumin Using Warfarin and Diazepam as Site Markers. Analytical Letters. 2009; 42:16: 2693-2710. DOI: 10.1080/00032710903243653
Legnerov
Mohamed NA, Ahmed S, El Zohny SA. Rapid and sensitive online determination of some selective ?1-blockers by flow injection analysis with micelle-enhanced fluorescence detection. J Fluoresc. 2013; 23(6):1301-11. doi: 10.1007/s10895-013-1264-0.
Shrivastava A, Gupta VB. HPLC: Isocratic or Gradient Elution and Assessment of Linearity in Analytical Methods. J Adv Scient Res. 2012; 3(2): 12-20.
Dokladalova J, Coco SJ, Lemke PR, Quercia GT, Korst JJ. Determination of polythiazide and prazosin in human plasma by high-performance liquid chromatography. J Chromatogr. 1981; 224(1):33-41.
Rathinavelu A, Malave A. High-performance liquid chromatography using electrochemical detection for the determination of prazosin in biological samples. J Chromatogr B Biomed Appl. 1995; 670(1):177-82.
Piotrovskii VK, Veiko NN, Ryabokon OS, Postolnikov SF, Metelitsa VI. Identification of a prazosin metabolite and some preliminary data on its kinetics in hypertensive patients. Eur J Clin Pharmacol 1984; 27:275-280.
Yee YG, Rubin PC, Meffin P. Prazosin determination by high-pressure liquid chromatography using fluorescence detection. J Chromatogr. 1979; 172:313-8.
Lin ET, Baughman RA Jr, Benet LZ. High-performance liquid chromatographic determination of prazosin in human plasma, whole blood and urine. J Chromatogr. 1980; 183(3):367-71.
Yamada S, Tanaka C, Suzuki M, Ohkura T, Kimura R, Kawabe K. Determination of ?1-adrenoceptor antagonists in plasma by radioreceptor assay. J Pharm Biomed Anal. 1996; 14: 289
Sultana N, Arayne MS, Naz S. Simultaneous determination of Prazosin and H2 receptor antagonists from bulk materials, pharmaceutical formulations and human serum by RP-HPLC. Inventi Impact: Pharm Ana & Qual Assur 01/2010; 1(2,):37.
Sultana N, Arayne MS, Shah SN. Liquid Chromatographic Analysis of Prazosin in API, Dosage Form and Serum: Application to Drug-Metal Interaction Studies. J Chromatograph Separat Techniq 4: 197. doi:10.4172/2157-7064.1000197.
Fouad F. Al-Qaim, Md P. Abdullah, Mohamed R. Othman, Jalifah Latip, Wan Afiq. A Validation Method Development for Simultaneous LC-ESI-TOF/MS Analysis of Some Pharmaceuticals in Tangkas River-Malaysia. J. Braz. Chem. Soc., 25(2): 271-281, 2014.
Sameh Ahmed, Niveen A. Mohamed, Sally A. El Zohny, A sensitive and reliable method for therapeutic monitoring of ?1-blockers in rabbit plasma by ion-pair chromatography with enhanced fluorescence detection, Microchem J. 2015. doi: 10.1016/j.microc.2015.05.006.
Shah SN, Sultana N, Hasan N, Arayne MS. Novel RP-HPLC method for simultaneous determination of Prazosin and NSAIDs in bulk, pharmaceutical formulations and human serum. World J Pharm Res 2015;4(7): 333-350.
Li AP, Peng H, Peng JD, Zhou MQ, Zhang J. Rayleigh light scattering detection of three a1-adrenoceptor antagonists coupled with high performance liquid chromatograph. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2015; 147:178
NA Mohamed, Ahmed S, El Zohny SA. A Specific High-Performance Thin-Layer Chromatography with Fluorescence Detection for the Determination of Some ?1-Blockers, Journal of Liquid Chromatography & Related Technologies, 2015;38:2:271-282, DOI: 10.1080/10826076.2014.903852
Naz S, Sultana N. Simultaneous determination of prazosin and calcium chanel blockers in raw materials, pharmaceutical formulations and human serum by RP-HPLC. Intern J Pharma Res Dev. 2010; 2(9): 6-10.
Legnerov
Hye-Sun G, In-Koo C. Simplified HPLC Method for the Determination of Prazosin in Human Plasma and Its Application to Single-dose Pharmacokinetics. Biomolecules and Therapeutics. 2005; 13(2), 90-94.
Bakshi M, Ojha T, Singh S. Validated specific HPLC methods for determination of prazosin, terazosin and doxazosin in the presence of degradation products formed under ICH-recommended stress conditions. J Pharm Biomed Anal. 2004; 34(1):19-26.
Shrivastava A, Gupta VB. Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Prazosin, Terazosin, and Doxazosin in Pharmaceutical Formulations. Sci Pharm. 2012; 80(3): 619
Shrivastava A, Gupta VB. Simultaneous Determination of Two Alpha-One Adrenoreceptor Blockers Terazosin and Prazosin Using Tamsulosin as Internal Standard. Inter J Pharm Pharma Sci, 2012; 4(3):752-756.
Ojha T, Bakshi M, Chakraborti AK, Singh S. The ICH guidance in practice: stress decomposition studies on three piperazinyl quinazoline adrenergic receptor-blocking agents and comparison of their degradation behaviour. J Pharm Biomed Anal. 2003; 31(4):775-83.
Bachman WJ. High Performance Liquid Chromatographic Determination of Diuretic-Antihypertensive Combination Products. I. Prazosin and Polythiazide, J Liquid Chromatogr, 1986; 9:5:1033-1049, DOI: 10.1080/01483918608076688.
Bhamra RK, Flanagan RJ, Holt DW. High-performance liquid chromatographic measurement of prazosin and terazosin in biological fluids. J Chromatogr. 1986; 380(1):216-21.
Belal TS, Mahrous MS, Abdel-Khalek MM, Daabees HG, Khamis MM. Validated HPTLC method for the simultaneous determination of alfuzosin, terazosin, prazosin, doxazosin and finasteride in pharmaceutical formulations. Analy Chem Res 2014; 1:23
Tenjarla SN, Tseggai A. High-performance liquid chromatographic assay of prazosin for transdermal screening studies. J Clin Pharm Ther. 1992; 17(1):37-42.
Shrivastava A, Gupta VB. Validated HPLC and HPTLC Methods for Simultaneous Determination of Some ?1-Adrenoreceptor Blockers. Lat Am J Pharm, 2012; 31(2): 279-86.
British Pharmacopoeia, 8th Edition, Volume III, 2015, The stationary office, London, pp. 1012-1013.
Indian Pharmacopoeia, Volume III, 2014, Ministery of Health and family welfare, Indian Pharmacopoeia Commission, Ghaziabad.
Japanese Pharmacopoeia. Supplement II to XV edition, The ministry of health, labour and welfare. pp. 2174-2175.
USP29
Shrivastava A, Analytical methods for venlaflaxine hydro-chloride and metabolites determinations in different matrices. Syst Rev Pharmacy 2012; 3:42-50. http://dx.doi.org/10.4103/0975-8453.107141.
Shrivastava A, Sharma J, Soni V. Various electroanalytical methods for the determination of uranium in different matrices, BFPCU, 2013;51(1):113
Khalil S, Kelzieh A, Ibrahim SA. Ion-selective electrode for the determination of prazosin in tablets. J Pharm Biomed Anal. 2003; 33(4):825-9.
Faridbod F, Ganjali MR, Larijani B, Nasli-Esfahani E, Riahi S, Norouzi P. Quantitative analysis of prazosin hydrochloride in pharmaceutical formulation by prazosin potentiometric sensor based on computational investigation. Int J Electrochem Sci 2010; 5:653
Guedes TJ, Alecrim MF, Oliveira FM, Lima AB, Barbosa SL, Santos WTP. Determination of prazosin in pharmaceutical samples by flow injection analysis with multiple-pulse amperometric detection using boron-doped diamond electrode. J Solid State Electrochem. 2015, DOI 10.1007/s10008-015-3105-3.
Soini H, Riekkola ML, Novotny MV. Mixed polymer networks in the direct analysis of pharmaceuticals in urine by capillary electrophoresis. J Chromatogr A. 1994; 680(2):623-34.
Chen Q, Li P, Yang H, Li B, Zhu J, Peng L. Nonaqueous capillary electrophoresis conditions for the simultaneous separation of eight alpha-adrenergicblocking agents. Anal Bioanal Chem. 2010, 398(2):937-42. doi: 10.1007/s00216-010-3973-4.
Rabieh S., Koushanpour A, Tajabadi F. Green and Straightforward Modification of Graphite Electrode via In Situ Synthesis of Graphene Nanosheets for Quantifying Prazosin Hydrochloride in Urine Samples and Pharmaceutical Formulations. Electroanalysis, 2015; 27: 2377
Stolarczyk M, Ma
Vincent J, Meredith PA, Reid JL, Elliott HL, Rubin PC. Clinical Pharmacokinetics of Prazosin
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
a) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
b)Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
After acceptance of the article, the author has to submit copyright form signed by all authors.